AMPAC Fine Chemicals Creating Jobs with Expansion in Virginia May 4, 2021
Investment will triple local employment and strengthen regional pharma industry
Furthers SK Group’s plans to invest in and grow U.S. businesses
AMPAC Fine Chemicals (AFC), an SK pharmteco company, is creating more than 150 new jobs and investing more than $25 million in its Petersburg, Va., site as part of a commitment to bring high-quality pharmaceutical manufacturing to the U.S.
In addition to the new jobs, AFC will expand the site’s capabilities by adding an East Coast presence for AMPAC Analytical Labs and enhanced R&D functions for continuous processing of pharmaceutical ingredients. AMPAC Analytical provides extensive development and testing services for the analysis, validation and release of intermediates and APIs
Biotech Innovation Company Aditxt to Establish State-of-the-Art Immune Monitoring Center in Richmond, VA
AditxtScore™ Center is the first of a planned immune monitoring network and will initially monitor COVID-19 immunity status;
New facility expects to target more than 300 jobs over three years to the area
Mountain View, CA and Richmond, VA – May 3, 2021 Aditxt (Aditx Therapeutics, Inc.) (Nasdaq: ADTX), a biotech innovation company focused on improving the health of the immune system, today announced plans to build a high-capacity AditxtScore™ Center in Richmond, VA in the second half of 2021. Aditxt is targeting a capital investment of $31.5 million over three years to scale up its state-of-the-art immune monitoring center, including projected new jobs, laboratory equipment, and construction. The announcement was made at a joint press conference with Governor Ralph Northam, Richmond Mayor Levar Stoney and other local business executives and political officials.
Immunity research firm Aditxt to invest $31.5M in new downtown lab
May 4, 2021
Gov. Ralph Northam presents a Virginia flag to Aditxt CEO Amro Albanna alongside Richmond Mayor Levar Stoney at an announcement about a new lab. (
Jonathan Spiers photo)
A Silicon Valley-based company that has developed a way to track immunity to diseases like COVID-19 is building a new lab at the VA Bio+Tech Park, where another multimillion-dollar project is getting another look.
Aditx Therapeutics, or Aditxt for short, announced Monday it will invest $31.5 million over three years to develop an immune monitoring center in the Bio+Tech 8 building at 737 N. Fifth St. on the downtown campus.